IL142017A0 - Human complement c3-degrading polypeptide from streptococcus pneumoniae - Google Patents
Human complement c3-degrading polypeptide from streptococcus pneumoniaeInfo
- Publication number
- IL142017A0 IL142017A0 IL14201799A IL14201799A IL142017A0 IL 142017 A0 IL142017 A0 IL 142017A0 IL 14201799 A IL14201799 A IL 14201799A IL 14201799 A IL14201799 A IL 14201799A IL 142017 A0 IL142017 A0 IL 142017A0
- Authority
- IL
- Israel
- Prior art keywords
- streptococcus pneumoniae
- human complement
- degrading polypeptide
- degrading
- polypeptide
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 230000000295 complement effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10173698P | 1998-09-24 | 1998-09-24 | |
| US28309499A | 1999-03-31 | 1999-03-31 | |
| PCT/US1999/022362 WO2000017370A1 (en) | 1998-09-24 | 1999-09-24 | HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142017A0 true IL142017A0 (en) | 2002-03-10 |
Family
ID=26798575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14201799A IL142017A0 (en) | 1998-09-24 | 1999-09-24 | Human complement c3-degrading polypeptide from streptococcus pneumoniae |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1115875A1 (de) |
| JP (1) | JP2002526082A (de) |
| KR (1) | KR20010089280A (de) |
| CN (1) | CN1352691A (de) |
| AU (1) | AU6060899A (de) |
| BR (1) | BR9914066A (de) |
| CA (1) | CA2343931A1 (de) |
| IL (1) | IL142017A0 (de) |
| MX (1) | MXPA01003073A (de) |
| WO (1) | WO2000017370A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69737125T3 (de) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
| US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| PT1140157E (pt) | 1998-12-21 | 2009-05-06 | Medimmune Inc | Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| NZ512574A (en) * | 1998-12-23 | 2004-03-26 | Iaf Biochem Int | Novel streptococcus antigens useful as vaccines |
| EP1950302B1 (de) | 1998-12-23 | 2012-12-05 | ID Biomedical Corporation of Quebec | Streptokokken-Antigene |
| US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| IL153558A0 (en) * | 2000-06-20 | 2003-07-06 | Shire Biochem Inc | Streptococcus antigens |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
| ES2387275T3 (es) * | 2003-05-15 | 2012-09-19 | Genentech, Inc. | Métodos y composiciones para la prevención y el tratamiento de la sepsis |
| ME01334B (me) | 2005-04-08 | 2013-12-20 | Wyeth Llc | Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| SI1940457T1 (sl) * | 2005-10-21 | 2013-04-30 | Catalyst Biosciences, Inc. | Modificirane proteaze, ki inhibirajo komplementno aktivacijo |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| AR058592A1 (es) | 2005-12-22 | 2008-02-13 | Glaxosmithkline Biolog Sa | Vacuna |
| CN101883583B (zh) | 2007-06-26 | 2017-05-17 | 葛兰素史密丝克莱恩生物有限公司 | 含有肺炎链球菌荚膜多糖缀合物的疫苗 |
| EP2612680B1 (de) | 2008-04-16 | 2018-05-23 | GlaxoSmithKline Biologicals SA | Impfstoff |
| GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US20140072622A1 (en) | 2011-05-17 | 2014-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine against streptococcus pneumoniae |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846547A (en) * | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
| DE69737125T3 (de) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
| BR9809405A (pt) * | 1997-04-24 | 2000-06-13 | Univ Minnesota | Proteinase de streptococcus pneumoniae que degrada complemento humano c3 |
| JP2001517449A (ja) * | 1997-09-24 | 2001-10-09 | リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ | ストレプトコッカス・ニューモニア由来のヒト補体ｃ３分解プロテイナーゼ |
-
1999
- 1999-09-24 EP EP99969446A patent/EP1115875A1/de not_active Withdrawn
- 1999-09-24 MX MXPA01003073A patent/MXPA01003073A/es unknown
- 1999-09-24 KR KR1020017003811A patent/KR20010089280A/ko not_active Application Discontinuation
- 1999-09-24 JP JP2000574269A patent/JP2002526082A/ja not_active Withdrawn
- 1999-09-24 WO PCT/US1999/022362 patent/WO2000017370A1/en not_active Application Discontinuation
- 1999-09-24 BR BR9914066-7A patent/BR9914066A/pt not_active Application Discontinuation
- 1999-09-24 CN CN99813016A patent/CN1352691A/zh active Pending
- 1999-09-24 AU AU60608/99A patent/AU6060899A/en not_active Abandoned
- 1999-09-24 CA CA002343931A patent/CA2343931A1/en not_active Abandoned
- 1999-09-24 IL IL14201799A patent/IL142017A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01003073A (es) | 2002-04-24 |
| BR9914066A (pt) | 2002-04-23 |
| WO2000017370A1 (en) | 2000-03-30 |
| EP1115875A1 (de) | 2001-07-18 |
| AU6060899A (en) | 2000-04-10 |
| CA2343931A1 (en) | 2000-03-30 |
| JP2002526082A (ja) | 2002-08-20 |
| CN1352691A (zh) | 2002-06-05 |
| KR20010089280A (ko) | 2001-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142017A0 (en) | Human complement c3-degrading polypeptide from streptococcus pneumoniae | |
| EP0914327A4 (de) | NEUE LysS-PROTEINE AUS STREPTOCOCCUS PNEUMONIAE | |
| IL123052A0 (en) | Thermoelectric product | |
| DE69728750D1 (en) | Strahlungs thermometer | |
| SG46750A1 (en) | Resistance thermometer | |
| AU3210299A (en) | Human galactosyl transferases | |
| EG21511A (en) | Pesticidal composition | |
| GB2336579B (en) | Detention unit | |
| AU4841499A (en) | Human transferases | |
| IL130046A0 (en) | Improved object manufacture | |
| PL335568A1 (en) | 1-aryl-pyrazoles exhibiting pesticidal properties | |
| IL123098A0 (en) | Placental protein 13 | |
| IL139873A0 (en) | Angoistatin-binding protein | |
| DE69820448D1 (en) | Tympanisches thermometer | |
| GB2333449B (en) | Hair manipulation | |
| PL343547A1 (en) | Streptococcus preparation | |
| GB9828880D0 (en) | Protein | |
| IL129566A0 (en) | Streptococcus uberis lactoferrin-binding protein | |
| AU132269S (en) | Thermometer | |
| EP1077258A4 (de) | Menschliches HRPI-Gen | |
| GB9624266D0 (en) | Improved cutlery | |
| GB2354522B (en) | DAP-kinase related protein | |
| GB9701588D0 (en) | Thermometer | |
| GB9812607D0 (en) | Protein | |
| GB9819038D0 (en) | Protein |